{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:32:16Z","timestamp":1790015536844,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jaci.2011.11.029","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T20:04:54Z","timestamp":1326744294000},"page":"1102-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Reduction of total IgE by targeted coengagement of IgE B-cell receptor and Fc\u03b3RIIb with Fc-engineered antibody"],"prefix":"10.1016","volume":"129","author":[{"given":"Seung Y.","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly M.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Pong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene W.L.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc-Hanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh S.","family":"Muchhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Bernett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Szymkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Desjarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.11.029_bib1","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72601","article-title":"The pharmacological basis of anti-IgE therapy","volume":"18","author":"Chang","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2011.11.029_bib3","first-page":"451","article-title":"Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy","volume":"20","author":"Kourtis","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib4","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.151.5.2623","article-title":"Humanization of an antibody directed against IgE","volume":"151","author":"Presta","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib5","doi-asserted-by":"crossref","first-page":"26368","DOI":"10.1016\/S0021-9258(18)47203-1","article-title":"The binding site on human immunoglobulin E for its high affinity receptor","volume":"269","author":"Presta","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.11.029_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000237058","article-title":"Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release","volume":"107","author":"Shields","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000237010","article-title":"Inhibition of allergic reactions with antibodies to IgE","volume":"107","author":"Shields","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib8","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI40141","article-title":"Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice","volume":"120","author":"Brightbill","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.11.029_bib9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell Fc\u03b5RI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib10","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJM199912233412603","article-title":"Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group","volume":"341","author":"Milgrom","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.029_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1185\/030079903125002171","article-title":"Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma","volume":"19","author":"Hochhaus","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2011.11.029_bib12","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.180.8.5499","article-title":"Targeting the extracellular membrane-proximal domain of membrane-bound IgE by passive immunization blocks IgE synthesis in\u00a0vivo","volume":"180","author":"Feichtner","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-2478(03)00078-6","article-title":"Feedback regulation by IgG antibodies","volume":"88","author":"Heyman","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2011.11.029_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ni1151","article-title":"The inhibitory Fc\u03b3 receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells","volume":"6","author":"Fukuyama","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib16","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.189.10.1573","article-title":"Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG","volume":"189","author":"Ujike","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.11.029_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.176.2.469","article-title":"Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as Fc\u03b3RII and Fc\u03b3RIII","volume":"176","author":"Takizawa","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.11.029_bib18","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.molimm.2008.06.027","article-title":"Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and Fc\u03b3RIIb with Fc-engineered antibodies","volume":"45","author":"Chu","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib19","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4049\/jimmunol.1003412","article-title":"Antibody-mediated coengagement of Fc\u03b3RIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus","volume":"186","author":"Horton","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000024043","article-title":"IgE inhibition as a therapy for allergic disease","volume":"118","author":"Jardieu","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib21","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.molimm.2006.09.029","article-title":"A molecular immunology approach to antibody humanization and functional optimization","volume":"44","author":"Lazar","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib22","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1093\/nar\/30.2.e9","article-title":"High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2011.11.029_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4161\/mabs.2.2.11158","article-title":"Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions","volume":"2","author":"Moore","year":"2010","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2011.11.029_bib24","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1535-7163.MCT-08-0201","article-title":"Optimization of antibody binding to Fc\u03b3RIIa enhances macrophage phagocytosis of tumor cells","volume":"7","author":"Richards","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jaci.2011.11.029_bib25","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1158\/0008-5472.CAN-08-2268","article-title":"Potent in\u00a0vitro and in\u00a0vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia","volume":"68","author":"Horton","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2011.11.029_bib26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1206954","article-title":"Inhibitory Fc\u03b3 receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies","volume":"333","author":"Li","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.11.029_bib27","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.4049\/jimmunol.0900300","article-title":"Suppression of IgE B cells and IgE binding to Fc\u03b5RI by gene therapy with single-chain anti-IgE","volume":"182","author":"Ota","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0161-5890(91)90030-N","article-title":"Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with Fc\u03b5RII and Fc\u03b5RI","volume":"28","author":"Keegan","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0161-5890(91)90132-4","article-title":"Monoclonal antibodies defining epitopes on human IgE","volume":"28","author":"Hook","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib30","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.172.6.1861","article-title":"CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells","volume":"172","author":"Jabara","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.11.029_bib31","first-page":"25","article-title":"Humanized SCID mouse models for biomedical research","volume":"324","author":"Pearson","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200302-239OC","article-title":"Roles of Fc\u03b3RIIB in nasal eosinophilia and IgE production in murine allergic rhinitis","volume":"169","author":"Watanabe","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2011.11.029_bib33","doi-asserted-by":"crossref","first-page":"e9337","DOI":"10.1371\/journal.pone.0009337","article-title":"Fc\u03b3RIIb inhibits allergic lung inflammation in a murine model of allergic asthma","volume":"5","author":"Dharajiya","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2011.11.029_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"Fc\u03b3RIIb controls bone marrow plasma cell persistence and apoptosis","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.immunol.21.120601.141138","article-title":"Regulatory mechanisms that determine the development and function of plasma cells","volume":"21","author":"Calame","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2011.11.029_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nri1572","article-title":"Regulation of plasma-cell development","volume":"5","author":"Shapiro-Shelef","year":"2005","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911018343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911018343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:31:43Z","timestamp":1758789103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911018343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0091674911018343"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.11.029","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of total IgE by targeted coengagement of IgE B-cell receptor and Fc\u03b3RIIb with Fc-engineered antibody","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}